Incidental Mutation 'R1317:Smad5'
ID 157578
Institutional Source Beutler Lab
Gene Symbol Smad5
Ensembl Gene ENSMUSG00000021540
Gene Name SMAD family member 5
Synonyms Madh5, Smad 5, MusMLP
MMRRC Submission 039383-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R1317 (G1)
Quality Score 225
Status Validated
Chromosome 13
Chromosomal Location 56850823-56890190 bp(+) (GRCm39)
Type of Mutation splice site
DNA Base Change (assembly) T to C at 56883884 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000105502 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000069557] [ENSMUST00000109874] [ENSMUST00000109876]
AlphaFold P97454
Predicted Effect probably benign
Transcript: ENSMUST00000069557
SMART Domains Protein: ENSMUSP00000065798
Gene: ENSMUSG00000021540

DomainStartEndE-ValueType
DWA 26 135 2.29e-68 SMART
low complexity region 186 214 N/A INTRINSIC
low complexity region 218 236 N/A INTRINSIC
DWB 269 441 1.24e-105 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000109874
SMART Domains Protein: ENSMUSP00000105500
Gene: ENSMUSG00000021540

DomainStartEndE-ValueType
DWA 26 135 2.29e-68 SMART
low complexity region 186 214 N/A INTRINSIC
low complexity region 218 236 N/A INTRINSIC
DWB 269 441 1.24e-105 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000109876
SMART Domains Protein: ENSMUSP00000105502
Gene: ENSMUSG00000021540

DomainStartEndE-ValueType
DWA 26 135 2.29e-68 SMART
low complexity region 186 214 N/A INTRINSIC
low complexity region 218 236 N/A INTRINSIC
DWB 269 441 1.24e-105 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000132302
Predicted Effect noncoding transcript
Transcript: ENSMUST00000136702
Predicted Effect noncoding transcript
Transcript: ENSMUST00000138677
Meta Mutation Damage Score 0.0898 question?
Coding Region Coverage
  • 1x: 98.7%
  • 3x: 97.5%
  • 10x: 93.7%
  • 20x: 84.9%
Validation Efficiency 100% (42/42)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PHENOTYPE: Homozygotes for targeted null mutations exhibit vascular, craniofacial, and neural tube defects, improper turning, edema, and a deficiency of primordial germ cells. Mutants die between embryonic days 10.5 and 11.5. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 31 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abi3bp C T 16: 56,488,672 (GRCm39) H1268Y possibly damaging Het
Afdn A G 17: 14,066,535 (GRCm39) T576A probably benign Het
Bcl6 G T 16: 23,796,292 (GRCm39) A45D probably damaging Het
Ccdc7b A T 8: 129,863,127 (GRCm39) H223L probably benign Het
Cdh15 G C 8: 123,584,234 (GRCm39) E112Q probably damaging Het
Cryba2 G T 1: 74,929,835 (GRCm39) probably null Het
Depdc1a T C 3: 159,228,924 (GRCm39) C559R probably damaging Het
Fam20a A T 11: 109,568,664 (GRCm39) N287K probably damaging Het
Gm5519 T C 19: 33,802,391 (GRCm39) Y145H possibly damaging Het
Gm9602 T A 14: 15,932,645 (GRCm39) I28N probably damaging Het
Gmeb1 G A 4: 131,962,198 (GRCm39) Q154* probably null Het
Gpr156 T C 16: 37,807,929 (GRCm39) L192P probably damaging Het
Hnrnpu G A 1: 178,157,822 (GRCm39) probably benign Het
Ifi209 A G 1: 173,465,029 (GRCm39) D53G possibly damaging Het
Irf6 G A 1: 192,851,609 (GRCm39) R400H probably damaging Het
Jag2 T A 12: 112,878,121 (GRCm39) M537L probably benign Het
Mid1 A C X: 168,769,090 (GRCm39) N215H probably damaging Het
Mt1 T C 8: 94,906,781 (GRCm39) probably benign Het
Myo15b C A 11: 115,774,460 (GRCm39) P2024Q probably null Het
Nphs1 C T 7: 30,181,256 (GRCm39) probably benign Het
Rbm27 G A 18: 42,457,116 (GRCm39) probably benign Het
Robo2 A G 16: 73,831,912 (GRCm39) V256A probably damaging Het
Rps24 A G 14: 24,541,830 (GRCm39) T6A probably damaging Het
Scg3 G A 9: 75,576,622 (GRCm39) T251M probably damaging Het
Slc25a23 T C 17: 57,360,888 (GRCm39) K179E possibly damaging Het
Tom1 T C 8: 75,778,179 (GRCm39) V87A probably benign Het
Trim30b T A 7: 104,006,542 (GRCm39) T105S possibly damaging Het
Tspan32 A G 7: 142,571,328 (GRCm39) M159V probably benign Het
Tubb1 A G 2: 174,298,689 (GRCm39) S124G probably benign Het
Zbtb1 A G 12: 76,433,573 (GRCm39) S520G probably benign Het
Zdhhc7 T A 8: 120,811,639 (GRCm39) H188L probably benign Het
Other mutations in Smad5
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00870:Smad5 APN 13 56,871,480 (GRCm39) missense probably benign 0.11
IGL01407:Smad5 APN 13 56,883,630 (GRCm39) missense probably benign 0.00
IGL02267:Smad5 APN 13 56,883,603 (GRCm39) splice site probably benign
IGL03014:Smad5 UTSW 13 56,883,754 (GRCm39) missense probably damaging 1.00
R2001:Smad5 UTSW 13 56,885,187 (GRCm39) missense probably damaging 0.99
R5401:Smad5 UTSW 13 56,875,282 (GRCm39) missense probably benign 0.00
R5551:Smad5 UTSW 13 56,883,654 (GRCm39) missense probably damaging 1.00
R5734:Smad5 UTSW 13 56,871,617 (GRCm39) missense probably damaging 1.00
R5796:Smad5 UTSW 13 56,871,645 (GRCm39) missense probably damaging 0.98
R5988:Smad5 UTSW 13 56,883,798 (GRCm39) missense probably damaging 0.99
R7557:Smad5 UTSW 13 56,875,282 (GRCm39) missense probably benign 0.00
R7769:Smad5 UTSW 13 56,880,855 (GRCm39) missense possibly damaging 0.95
R8110:Smad5 UTSW 13 56,871,701 (GRCm39) missense probably damaging 1.00
R9215:Smad5 UTSW 13 56,880,815 (GRCm39) missense probably damaging 1.00
R9369:Smad5 UTSW 13 56,885,242 (GRCm39) missense possibly damaging 0.86
R9432:Smad5 UTSW 13 56,875,417 (GRCm39) missense probably benign 0.00
Z1088:Smad5 UTSW 13 56,876,441 (GRCm39) missense probably benign
Predicted Primers PCR Primer
(F):5'- GCATTACTGGAGTTTGCTGTGCATC -3'
(R):5'- GCTGAAACTCACCACTCTGAGTCTC -3'

Sequencing Primer
(F):5'- AGTGTCTTAGTGACAGCAGCATC -3'
(R):5'- CTCAGGCCATGAGAGTGAC -3'
Posted On 2014-02-18